Fenofibric Acid Capsule, Delayed Release
Product Images NDC 46708-244

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Fenofibric Acid (NDC 46708-244). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Alembic Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

30's Bottle Pack (Fenofibricacid 135mg)

This is a prescription medication with the NDC code 46708-245-30. It is important not to use the medication if the bottle's seal is broken or missing. Each capsule contains the equivalent of 135 mg of fenofibrate, an antilipemic agent that is an analog of clofibrate. The capsules have a delayed-release formulation and should be stored at room temperature between 15°C to 30°C (59°F to 86°F) protected from moisture. The medication guide provided with the medication should be given to the patient by the pharmacist. Detailed information can be found on the package insert.*

FDA Label Image

30's Bottle Pack (Fenofibricacid 45mg)

This appears to be a medication label. It warns not to accept the bottle if the seal is broken or missing. The medication is a delayed-release capsule containing Fenofibric Acid of strength 125 (17F). The storage temperature should be between 59 to 86°F. The pharmacist has to dispense the medication along with a medication guide to the patient. The rest of the text is not readable.*

FDA Label Image

Structure (Fenofibricacid Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.